Type 1 diabetes good news

I have type 2, but still…

“By 12 months after the start of the study, the placebo group had needed to increase their injected insulin doses by an average of 50 per cent. But those who received the immunotherapy remained stable, with no need to increase their insulin doses and no signs of accelerated beta cell destruction. No adverse reactions were seen.”



Type 1 diabetes is an autoimmune disease. Type 2 diabetes is a metabolic disease. They are completely different. This study is only applicable to type 1, the autoimmune type.